Loading…
Tenax Therapeutics, Inc. is projected to rise to $15.75 by 2027, a +15% move from its current price of $13.70. TENX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $13.08 | $13.69 | $14.33 | -0.06% |
| Aug 4 | $12.83 | $13.68 | $14.60 | -0.13% |
| Aug 5 | $12.63 | $13.67 | $14.80 | -0.19% |
| Aug 6 | $12.47 | $13.66 | $14.97 | -0.26% |
| Aug 7 | $12.33 | $13.66 | $15.12 | -0.32% |
| Aug 8 | $12.20 | $13.65 | $15.26 | -0.39% |
| Aug 9 | $12.09 | $13.64 | $15.39 | -0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.09 | $13.64 | $15.39 | -0.45% |
| Week 2 | $11.44 | $13.58 | $16.11 | -0.90% |
| Week 3 | $10.96 | $13.52 | $16.66 | -1.35% |
| Week 4 | $10.57 | $13.45 | $17.13 | -1.80% |
| Week 5 | $10.22 | $13.39 | $17.55 | -2.24% |
| Week 6 | $9.92 | $13.33 | $17.93 | -2.68% |
| Week 7 | $9.64 | $13.27 | $18.27 | -3.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenax Therapeutics, Inc. is a development-stage pharmaceutical company focused on cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.
The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Tenax Therapeutics, Inc. (TENX) is a healthcare stock with current price $13.70 and market cap $363.39M. It holds a position outside the top ranks at rank 3276, reflecting its smaller market capitalization and niche clinical focus within the sector.
The forecast path provides a long-horizon growth trajectory, with 2026 averaging $13.70, rising through 2029 to $25.13 and 2030 to $31.42. By 2035 the average is $52.89, by 2040 $67.12, and by 2050 $164.98. Along this path, forecasted ROI progresses to 129.3% by 2030 and climbs to 1104.2% by 2050, with sentiment evolving to bullish in the later years.
A major floor 39.0% below — a decisive break under it would weaken the trend.
The nearest floor, 12.4% below — buyers have tended to step in here.
The nearest ceiling, 33.7% above — a clean break opens room to run.
A major ceiling 53.2% above — clearing it would confirm fresh momentum.
Key TENX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TENX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.12 | Sell | $14.71 | Sell |
| MA 10 | $15.10 | Sell | $15.02 | Sell |
| MA 20 | $15.80 | Sell | $15.01 | Sell |
| MA 50 | $13.56 | Buy | $14.25 | Sell |
| MA 100 | $13.69 | Buy | $13.52 | Buy |
| MA 200 | $12.25 | Buy | $12.27 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.39 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -158.23 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.30 | Sell |
| ROC (12) | -10.69 | Sell |
| Bollinger %B (20,2) | 0.05 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.60 | Buy |
| Awesome (5,34) | 0.53 | Buy |
| Ultimate (7,14,28) | 40.06 | Neutral |
| Momentum (10) | -2.15 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 14.78 | Sell |
| ADX (14) | 15.54 | Neutral |
| ATR (14) | 0.65 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI14 is 40, with the 50-day simple moving average at $13.56 and the 200-day simple moving average at $12.25, suggesting the price is hovering around key trend lines.
Near-term support sits at $12.00 and resistance at $18.32. The stock has traded within a 30-day range of $10.14 to $18.51, indicating a broad move but with upside potential above the near-term support. Annualized volatility is high at 90%, reflecting substantial price swings.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.54 | $13.70 | $17.86 | 0% | Neutral | |
| $11.79 | $15.75 | $22.63 | +15% | Neutral | |
| $13.38 | $18.80 | $28.60 | +37% | Bullish | |
| $17.13 | $25.13 | $39.96 | +83% | Bullish | |
| $20.61 | $31.42 | $51.82 | +129% | Bullish | |
| $20.79 | $32.84 | $55.88 | +140% | Bullish | |
| $20.42 | $33.37 | $58.38 | +144% | Bullish | |
| $19.69 | $33.22 | $59.59 | +142% | Bullish | |
| $22.01 | $38.30 | $70.30 | +180% | Bullish | |
| $29.49 | $52.89 | $99.13 | +286% | Bullish | |
| $32.44 | $67.12 | $137.17 | +390% | Bullish | |
| $74.24 | $164.98 | $379.45 | +11.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $10.54 | $13.70 | $16.62 | +0.00% |
| September 2026 | $10.59 | $12.77 | $16.02 | -6.77% |
| October 2026 | $10.58 | $12.91 | $16.48 | +1.11% |
| November 2026 | $11.14 | $13.73 | $17.76 | +6.30% |
| December 2026 | $10.96 | $13.63 | $17.86 | -0.72% |
Click any year to see its month-by-month TENX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TENX is projected to trade between $10.54 and $17.86, averaging $13.70 — a potential gain of 0% from today's $13.70. Price action looks broadly range-bound.
Tenax Therapeutics, Inc.'s 2027 outlook centres on $15.75, within a $11.79 to $22.63 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, TENX could reach as high as $28.60, with a base case around $18.80 and support toward $13.38 — roughly +37% from $13.70. Momentum favours further upside here.
Expect TENX to range from $17.13 to $39.96 through 2029. The $25.13 average target implies a +83% move from current prices. That is up +34% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The TENX price prediction for 2030 points to an average of $31.42 (low $20.61, high $51.82) — a potential gain of +129% on today's $13.70. Momentum favours further upside here.
In 2031, TENX is projected to trade between $20.79 and $55.88, averaging $32.84 — a potential gain of +140% from today's $13.70. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Tenax Therapeutics, Inc.'s 2032 outlook centres on $33.37, within a $20.42 to $58.38 range. That is up +2% on the projected 2031 average. That marks a +144% change versus current levels. Momentum favours further upside here.
By 2033, TENX could reach as high as $59.59, with a base case around $33.22 and support toward $19.69 — roughly +142% from $13.70. Buyers look set to stay in control over this stretch.
Expect TENX to range from $22.01 to $70.30 through 2034. The $38.30 average target implies a +180% move from current prices. That is up +15% on the projected 2033 average. Momentum favours further upside here.
The TENX price prediction for 2035 points to an average of $52.89 (low $29.49, high $99.13) — a potential gain of +286% on today's $13.70. Buyers look set to stay in control over this stretch.
In 2040, TENX is projected to trade between $32.44 and $137.17, averaging $67.12 — a potential gain of +390% from today's $13.70. That is up +27% on the projected 2035 average. Momentum favours further upside here.
Tenax Therapeutics, Inc.'s 2050 outlook centres on $164.98, within a $74.24 to $379.45 range. That is up +146% on the projected 2040 average. That marks a +11.0x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in TENX today (≈ 72.992701 TENX) could be worth
$12,042.15
+$11,042.15 (+1104%) by 2050 · US Dollar
Based on the average projected TENX price of $164.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TENXwould be worth at today's price.
$1,000 invested in TENX on Jul 31, 2025 (≈ 160.256416 TENX) would be worth
$2,195.51
+$1,195.51 (+119.6%) today · 2.20× · US Dollar
Based on a TENX entry price of $6.24 vs. today's $13.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.53 | $942.88 | -5.7% |
| 1 month ago | $13.29 | $1,030.85 | +3.1% |
| 3 months ago | $12.78 | $1,071.99 | +7.2% |
| 6 months ago | $12.95 | $1,057.92 | +5.8% |
| 1 year ago | $6.24 | $2,195.51 | +119.6% |
| All time (5.0y) ago | $2,624 | $5.22 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TENX forecast.
Our base-case forecast reaches $27.00 around 2030.
Implied market cap at $27.00: $716.18M
The multi-year forecast depicts a bullish trajectory across the horizon. For 2026, the expected average price is $13.70 with a neutral sentiment and an average around that level, while 2027 shows an average of $15.75 with a 14.9% ROI. The path strengthens markedly from 2028 onward, with 2028 average $18.80 (37.2% ROI), 2029 average $25.13 (83.4% ROI), and 2030 average $31.42 (129.3% ROI).
Beyond 2030, the forecast continues to rise: 2031 average $32.84 (139.7% ROI), 2032 $33.37 (143.5%), 2033 $33.22 (142.5%), 2034 $38.30 (179.6%), and 2035 $52.89 (286.1%). The long-horizon view remains bullish with 2040 average $67.12 (389.9% ROI) and 2050 average $164.98 (1104.2% ROI). These figures illustrate a persistent upward trajectory, though they are estimates and not guaranteed.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $20.61, an average of $31.42, and a max of $51.82, with a ROI of 129.3% and sentiment BULLISH.
Forecasts show rising averages from 2026 at $13.70 to 2050 at $164.98, with potential max up to $379.45 and ROI reaching 1104.2% by 2050. Sentiment improves over time to BULLISH in the longer horizon, but these are estimates, not guarantees.
Yes, the forecasted maxima include $99.13 in 2035, $137.17 in 2040, and $379.45 in 2050, indicating that crossing $100 is within the projected path by the mid-to-late horizon.
$363.39M.
Tenax Therapeutics, Inc. Community Discussion
0Share your Tenax Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.